Risk Assessment for Antimicrobial Agent‐Induced QTc Interval Prolongation and Torsades de Pointes
- 1 March 2001
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 21 (3) , 301-319
- https://doi.org/10.1592/phco.21.3.301.34206
Abstract
Over the past several years a multitude of new pharmaceutical agents have been released to the market. Several of them were withdrawn altogether or their use severely restricted to certain indication...Keywords
This publication has 90 references indexed in Scilit:
- Measurement and interpretation of QT dispersionProgress in Cardiovascular Diseases, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Comparative Tolerability of the Newer Fluoroquinolone AntibacterialsDrug Safety, 1999
- Safety of trovafloxacin in treatment of lower respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Systemic Antifungal AgentsDrug Safety, 1998
- Torsades de pointe probably related to sparfloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variabilityAmerican Heart Journal, 1996
- Torsade de PointesDrugs, 1994
- The Spectrum of Symptoms and QT Intervals in Carriers of the Gene for the Long-QT SyndromeNew England Journal of Medicine, 1992
- Pentamidine-induced torsade de pointesAmerican Heart Journal, 1991